Structural biologist Nicolas Fawzi will direct Brown’s role in a multi-institution project to transform the understanding of cellular protein dysfunction in the earliest stages of neurodegenerative disease.

A new study investigates the shared genetic link between the two degenerative conditions, treating them for the first time as a single disease spectrum.

A cognitive researcher at Brown University is leading the Rhode Island team in a multi-city initiative, called the HEAD study, focused on detecting tau to speed Alzheimer’s diagnoses.

A study led by Brown University researchers found that older adults who received the shingles vaccine currently used in the U.S. were less likely to be diagnosed with dementia within four years.

Brown University is among a series of organizations that have supported the launch of Ocean State Labs, which aims to propel growth among life sciences and biotech ventures in Rhode Island.

Three trainee-led startups are on a mission to fight Alzheimer's disease.

This year’s awardees are making key contributions to the study of addiction, ALS, Alzheimer’s disease, anxiety and traumatic injury.

The findings could help clinicians use neuropsychiatric symptoms to prepare patients and families for a type of dementia previously only diagnosed via autopsy.

Researchers from Brown University and the University of Rochester will lead a multi-institution project to test whether reducing DNA-triggered inflammation can help older adults stay healthier for longer.

Ted Wilson joined Brown’s Center for Alzheimer’s Disease Research as Provost’s Assistant Professor of Brain Science and Neuroimmunology in December, 2025. Wilson holds a PhD in neuroscience from McGill University, and is joining Brown from Stanford, where he completed post-doctoral training and started his own research laboratory two years ago.